[go: up one dir, main page]

WO2009138198A3 - Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders - Google Patents

Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders Download PDF

Info

Publication number
WO2009138198A3
WO2009138198A3 PCT/EP2009/003317 EP2009003317W WO2009138198A3 WO 2009138198 A3 WO2009138198 A3 WO 2009138198A3 EP 2009003317 W EP2009003317 W EP 2009003317W WO 2009138198 A3 WO2009138198 A3 WO 2009138198A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxytyrosol
intestinal tract
compositions
preventive
curative treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/003317
Other languages
French (fr)
Other versions
WO2009138198A2 (en
Inventor
Felicia Cisale
Luciano Villanova
Azzurra Villanova
Alessandro Merendino
Gianluca Fasiello
Luigi Villanova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Original Assignee
Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino filed Critical Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Publication of WO2009138198A2 publication Critical patent/WO2009138198A2/en
Publication of WO2009138198A3 publication Critical patent/WO2009138198A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are oral compositions with enhanced release in the intestinal tract which contain hydroxytyrosol as active ingredient, and possibly a soluble dietary fibre.
PCT/EP2009/003317 2008-05-14 2009-05-11 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders Ceased WO2009138198A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000869A ITMI20080869A1 (en) 2008-05-14 2008-05-14 HYDROXYSEROSOLO-BASED COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF INTESTINAL TRACT PATHOLOGIES
ITMI2008A000869 2008-05-14

Publications (2)

Publication Number Publication Date
WO2009138198A2 WO2009138198A2 (en) 2009-11-19
WO2009138198A3 true WO2009138198A3 (en) 2010-03-04

Family

ID=40302738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/003317 Ceased WO2009138198A2 (en) 2008-05-14 2009-05-11 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders

Country Status (2)

Country Link
IT (1) ITMI20080869A1 (en)
WO (1) WO2009138198A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1623960A1 (en) * 2004-08-06 2006-02-08 Lachifarma SRL Laboratorio Chimico Farmaceutico Salentino Process for the recovery of tyrosol and hydroxytyrosol from oil mill wastewaters and catalytic oxidation method in order to convert tyrosol in hydroxytyrosol
US20060257351A1 (en) * 2001-10-09 2006-11-16 Fancel Corporation Compositions for potentiating glutatthione
WO2008006581A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
EP2027781A1 (en) * 2007-08-21 2009-02-25 DSMIP Assets B.V. Method of removal of bitter taste from olive juice extract

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257351A1 (en) * 2001-10-09 2006-11-16 Fancel Corporation Compositions for potentiating glutatthione
EP1623960A1 (en) * 2004-08-06 2006-02-08 Lachifarma SRL Laboratorio Chimico Farmaceutico Salentino Process for the recovery of tyrosol and hydroxytyrosol from oil mill wastewaters and catalytic oxidation method in order to convert tyrosol in hydroxytyrosol
WO2008006581A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
EP2027781A1 (en) * 2007-08-21 2009-02-25 DSMIP Assets B.V. Method of removal of bitter taste from olive juice extract

Also Published As

Publication number Publication date
ITMI20080869A1 (en) 2009-11-15
WO2009138198A2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
WO2009064460A3 (en) Gastrointestinal delivery systems
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
WO2008151299A3 (en) Implantable medical devices for local and regional treatment
EP4538227A3 (en) Sodium thiosulfate-containing pharmaceutical compositions
IL207038A (en) Diazaspiro[5.5]undecane derivatives, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for treating or reducing the risk of an inflammatory disease or condition
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
WO2010132882A8 (en) Sublingual dexmedetomidine compositions and methods of use thereof
IL223783B (en) Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
EP2315582A4 (en) Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
WO2007109160A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009073307A3 (en) Implantable medical devices for local and regional treatment
WO2011037411A3 (en) Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2011044523A3 (en) Compositions and methods for treating obesity
WO2009142428A3 (en) Pharmaceutical composition for the treatment of premature ejaculation
WO2007083190A8 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
WO2012040082A3 (en) Antidiabetic solid pharmaceutical compositions
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
WO2008094054A3 (en) 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
WO2007116297A3 (en) Use of aminapthone for the preparation of a medicament for treating arteriophaties

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09745532

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09745532

Country of ref document: EP

Kind code of ref document: A2